查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1877415

分子诊断原料酶市场：按技术、酵素类型、最终用户、应用、组成、国家和地区划分－全球产业分析、市场规模、市场份额及2025-2032年预测

Molecular Diagnostic Raw Enzyme Market, By Technology, By Enzyme Type, By End-User, By Application, By Component, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 389 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年分子诊断原料酶市场规模为 12.9856 亿美元，从 2025 年到 2032 年将以 9.4% 的复合年增长率成长。

分子诊断原料酶市场涵盖聚合酶、连接酶和逆转录酶等关键生物催化剂，这些催化剂广泛应用于PCR、qPCR、次世代定序和其他分子检测平台，以精确检测遗传物质。市场成长的主要驱动力是传染病、肿瘤和基因筛检等领域对先进分子诊断技术的需求不断增长，加速了酵素的消耗。然而，高昂的生产成本和严格的纯度要求限制了市场成长，为经济高效的大规模生产带来了挑战。同时，即时诊断和快速PCR系统的新机会也为市场带来了益处，推动了对特化和工程化酶变体的需求。利用重组酶、高保真度酶和耐热酶来提高现代诊断工作流程的敏感度、速度和多重检测能力，是塑造市场格局的主要趋势。

分子诊断原料酵素市场－市场动态

癌症和传染病发生率上升

全球癌症和传染病发病率的不断上升推动了对分子诊断原料酶的需求。聚合酶、连接酶和逆转录酶是早期检测、监测和管理这些疾病的检测方法中的重要组成部分。快速且准确的分子诊断能够实现及时干预，从而改善患者预后并支持个人化医疗。据估计，到2024年，美国将新增约200万例癌症病例，而美国疾病管制与预防中心（CDC）也报告了麻疹、登革热和I型脓痘等重大传染病疫情。这些日益严峻的医疗挑战正在推高对分子诊断的需求，进而增加了对用于PCR、定序和其他分子检测的高品质原料酶的需求。

分子诊断原料酵素市场細項分析：

全球市场按技术、酵素类型、最终用户、应用、组件和地区进行细分。

分子诊断原料酵素市场主要分为肿瘤学、传染病学、心臟病学和其他领域。其中，传染病应用占据了分子诊断原料酶市场相当大的份额，这主要得益于快速、精准病原体检测需求的不断增长。诸如聚合酶炼式反应 (PCR) 和下一代定序 (NGS) 等先进的分子诊断技术高度依赖高品质的原料酶来准确识别结核病、HIV 和病毒感染等病原体。主要市场参与者正积极开发新型酵素製剂和自动化诊断解决方案，以推动该领域的成长。例如，2022 年 5 月，BD 公司在美国推出了全自动 BD COR MX 系统，该系统可在极少人工干预的情况下处理多达 1700 个样本，并能检测沙眼衣原体、淋病奈瑟菌和阴道毛滴虫等病原体。这项进展强调了可靠的原始酵素在提高检测效率、通量和准确性方面的重要性，尤其是在传染病诊断方面。

分子诊断原料酶市场按技术类型分为酵素连结免疫吸附试验 (ELISA)、聚合酶炼式反应 (PCR) 和其他技术。 PCR 技术因其在实现精准、高通量分子诊断中的关键作用而占据重要地位。定量 PCR、逆转录 PCR、反向 PCR 和多重 PCR 等 PCR 技术被广泛用于同时检测多个靶标，其中即时 PCR 在癌症标记分析中发挥重要作用。高通量 PCR 技术的日益普及催生了对高品质原料酶的需求，以确保精确扩增和结果的可重复性。例如，赛默飞世尔科技 (Thermo Fisher Scientific) 于 2023 年发布的 QuantStudio Absolute Q AutoRun dPCR 套件可实现实验室工作流程自动化，从而提高效率并降低营运成本；而罗氏 (Roche) 于 2022 年发布的 Digital LightCycler 系统则提升了癌症检测和生物标誌物分析能力。这些进展凸显了 PCR 酶在肿瘤学、传染病和基因检测等分子诊断中的关键作用。

分子诊断原料酵素市场—地理分布分析

预计到2025年，北美将成为诊断分子原料酶市场的重要收入来源地区，这主要得益于其完善的医疗保健基础设施，为先进的诊断检测提供了有力支持。该地区对创新体外诊断（IVD）平台的广泛应用，也带动了对用于各种诊断应用的原料酶的需求成长。此外，研发投入的不断增加以及患者群体的持续扩大，进一步促进了诊断分子原料酶的使用，巩固了该地区在维持整体市场成长方面的重要性。

加拿大分子诊断原料酶市场—国家概况

预计加拿大分子诊断原料酶市场在预测期内将显着成长。癌症和其他慢性疾病的日益普遍，推动了对先进分子诊断解决方案的需求，以实现早期检测和个人化治疗。根据加拿大癌症协会估计，到2024年，加拿大将有247,100人被诊断出患有癌症，高于2023年的239,100例新增病例，这主要是由于该国人口老化和增长所致。此外，预计癌症相关死亡人数将从2023年的86,700人增加到2024年的88,100人，凸显了对准确及时的诊断工具日益增长的需求。这一趋势预计将推动分子诊断原料酶的应用，这些原料酶是PCR、定序和其他诊断检测的关键组成部分，从而促进加拿大市场的成长。

分子诊断原料酵素市场－竞争格局：

分子诊断原料酵素市场竞争格局集中度适中，少数几家关键企业主导创新与市场扩张。赛默飞世尔科技（Thermo Fisher Scientific）、默克集团（Merck KGaA）和新英格兰生物实验室（New England Biolabs）等公司专注于开发高性能酶，这些酶具有更高的稳定性、特异性和可重复性，适用于PCR、NGS和传染病检测等分子诊断应用。例如，默克集团于2024年发布了其DNA聚合酶的升级版，该酵素的扩增保真度提高了12%，并提升了临床诊断实验室的效率。对准确可靠的酵素解决方案日益增长的需求、监管合规性要求以及先进分子检测技术的广泛应用，都对市场竞争产生影响。各公司持续加大研发投入、拓展合作、丰富产品组合，以满足全球医院、研究机构和体外诊断实验室不断变化的诊断需求。

目录

第一章：分子诊断原料酵素市场概览

  • 研究范围
  • 市场估算年份

第二章：执行概要

  • 市集
    • 分子诊断原料酵素市场技术概览
    • 分子诊断原料酵素市场概览（依酵素类型划分）
    • 分子诊断原料酶市场按最终用户分類的概况
    • 分子诊断原料酶市场按应用领域分類的概览
    • 分子诊断原料酵素市场按成分分類的概览
    • 各国分子诊断原料酵素市场概况
    • 分子诊断原料酵素市场区域概览
  • 竞争洞察

第三章：分子诊断原料酵素市场关键趋势

  • 分子诊断原料酶市场驱动因素
    • 市场驱动因素的影响分析
  • 分子诊断原料酵素市场限制因素
    • 市场限制因素的影响分析
  • 分子诊断原料酵素市场机会
  • 分子诊断原料酵素市场未来趋势

第四章：分子诊断原料酶产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景分析
  • 规范架构分析

第五章：分子诊断原料酶市场：地缘政治紧张局势升级的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：分子诊断原料酵素市场概况

  • 2024年分子诊断原料酵素市场占有率分析
  • 主要製造商细分数据
    • 知名球员分析
    • 新兴参与者分析

第七章：分子诊断原料酶市场－依技术划分

  • 概述
    • 按技术分類的细分市场份额分析
    • 酵素连结免疫吸附试验（ELISA）
    • 聚合酶炼式反应（PCR）
    • 其他的

第八章：分子诊断原料酶市场－依酵素类型划分

  • 概述
    • 按酵素类型分類的细分市场份额分析
    • 聚合酶和转录酶
    • 核糖核酸酶
    • 蛋白酶
    • 其他的

第九章：分子诊断原料酶市场－以最终用户划分

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 生物技术和製药公司
    • 医院和诊断实验室
    • 其他的

第十章：分子诊断原料酶市场－依应用领域划分

  • 概述
    • 按酵素类型分類的细分市场份额分析
    • 肝功能生化诊断
    • DNA检测
    • 传染病诊断
    • 肿瘤诊断
    • 凝血诊断
    • 其他的

第十一章：分子诊断原料酵素市场－依成分划分

  • 概述
    • 按组成部分分類的细分市场占有率分析
    • 肿瘤学
    • 传染病
    • 心臟病学
    • 其他的

第十二章：分子诊断原料酶市场－依地理划分

  • 介绍
    • 按地域分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美分子诊断原料酵素主要生产商
    • 北美市场规模及预测（按国家/地区划分）
    • 北美市场规模及预测（依技术划分）
    • 北美市场规模及预测（依酵素类型划分）
    • 北美市场规模及预测（依最终用户划分）
    • 北美市场规模及预测（按应用划分）
    • 北美市场规模及预测（按组件划分）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲分子诊断原料酵素主要生产商
    • 欧洲市场规模及预测（按国家/地区划分）
    • 欧洲市场规模及预测（依技术划分）
    • 欧洲市场规模及预测（依酵素类型划分）
    • 欧洲市场规模及预测（依最终用户划分）
    • 欧洲市场规模及预测（按应用领域划分）
    • 欧洲市场规模及预测（按组件划分）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区
    • 概述
    • 亚太地区分子诊断原料酵素主要生产商
    • 亚太市场规模及预测（依国家/地区划分）
    • 亚太市场规模及预测（依技术划分）
    • 亚太地区市场规模及预测（依酵素类型划分）
    • 亚太市场规模及预测（依最终用户划分）
    • 亚太市场规模及预测（按应用划分）
    • 亚太市场规模及预测（依组件划分）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲分子诊断原料酵素主要生产商
    • 拉丁美洲市场规模及预测（按国家/地区划分）
    • 拉丁美洲市场规模及预测（依技术划分）
    • 拉丁美洲市场规模及预测（按酵素类型划分）
    • 拉丁美洲市场规模及预测（按最终用户划分）
    • 拉丁美洲市场规模及预测（按应用划分）
    • 拉丁美洲规模及预测（按组成部分）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲分子诊断原料酵素主要生产商
    • 中东和非洲市场规模及预测（按国家/地区划分）
    • 中东和非洲市场规模及预测（按技术划分）
    • 中东和非洲市场规模及预测（按酵素类型划分）
    • 中东和非洲市场规模及预测（按最终用户划分）
    • 中东和非洲市场规模及预测（按应用划分）
    • 中东和非洲市场规模及预测（按组件划分）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 中东和非洲其他地区

第十三章：分子诊断原料酵素产业主要供应商分析

  • 竞争基准化分析
    • Competitive Dashboard
    • Competitive Positioning
  • 公司简介
    • New England Biolabs (NEB)
    • QIAGEN
    • Bio-Rad Laboratories
    • Takara Bio
    • Aldevron
    • Codexis
    • Thermo Fisher Scientific
    • Vazyme Biotech
    • Qiagen
    • Fapon Biotech
    • Yeasen Biotechnology
    • Amano Enzyme Inc.
    • Advanced Enzymes Technologies Ltd.
    • Biocatalysts Ltd.
    • Enzo Life Sciences
    • MP Biomedicals
    • BBI Solutions
    • EKF Diagnostics
    • Medix Biochemica
    • Canvax Biotech
    • Others

第十四章：360度分析师视角

第十五章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5758

The Molecular Diagnostic Raw Enzyme Market size was valued at US$ 1,298.56 Million in 2024, expanding at a CAGR of 9.4% from 2025 to 2032.

The Molecular Diagnostic Raw Enzyme Market includes essential biological catalysts like polymerases, ligases, and reverse transcriptases, which are used in PCR, qPCR, next-generation sequencing, and other molecular testing platforms to detect genetic material accurately. The market is being driven by increased demand for advanced molecular diagnostics in infectious disease, oncology, and genetic screening applications, which is accelerating enzyme consumption. However, high manufacturing costs and stringent purity requirements limit growth, posing challenges for cost-effective large-scale production. At the same time, the market benefits from new opportunities in point-of-care diagnostics and rapid PCR systems, which drive demand for specialized and engineered enzyme variants. The use of recombinant, high-fidelity, and thermostable enzymes to improve sensitivity, speed, and multiplexing capabilities in modern diagnostic workflows is a major trend shaping the landscape.

Molecular Diagnostic Raw Enzyme Market- Market Dynamics

Rising Prevalence of Cancer and Infectious Diseases

The rising prevalence of cancer and infectious diseases worldwide is driving demand for molecular diagnostic raw enzymes. Polymerases, ligases, and reverse transcriptases are important components in assays for early detection, monitoring, and management of these conditions. Rapid and accurate molecular diagnostics allow for timely interventions, which improves patient outcomes and supports personalized medicine approaches. According to estimates for 2024, approximately 2 million new cancer cases will be diagnosed in the United States, while the CDC has reported significant infectious disease outbreaks such as measles, dengue fever, and a Clade I mpox case. These growing healthcare challenges are driving up demand for molecular diagnostics, which in turn increases the demand for high-quality raw enzymes for PCR, sequencing, and other molecular assays.

Molecular Diagnostic Raw Enzyme Market- Segmentation Analysis:

The worldwide market is segmented on the basis of Technology, Enzyme Type, End-User, Application, Component, and Region.

The Molecular Diagnostic Raw Enzyme market component is primarily categorized into Oncology, Infectious Diseases, Cardiology, and Others. Among which. The infectious disease application accounts for a significant portion of the Molecular Diagnostic Raw Enzyme Market, driven by rising demand for rapid and precise pathogen detection. Advanced molecular diagnostic techniques, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), rely heavily on high-quality raw enzymes to accurately identify pathogens like tuberculosis, HIV, and viral infections. Key market players are actively supporting the expansion of this segment by developing novel enzyme formulations and automated diagnostic solutions. For instance, in May 2022, BD introduced the fully automated BD COR MX system in the United States, which can process up to 1,700 specimens with minimal staff interaction while detecting pathogens such as Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis. This advancement emphasizes the importance of dependable raw enzymes in improving testing efficiency, throughput, and accuracy, especially in infectious disease diagnostics.

Molecular Diagnostic Raw Enzyme Market Technology type is divided into Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR), and Others, The PCR segment is an important one due to its critical role in enabling accurate and high-throughput molecular diagnostics. PCR technologies, such as quantitative PCR, reverse transcription PCR, inverse PCR, and multiplex PCR, are widely used to detect multiple targets at once, with real-time PCR playing an important role in cancer marker analysis. The growing use of high-throughput PCR techniques has created a demand for high-quality raw enzymes to ensure precise amplification and reproducible results. For example, Thermo Fisher Scientific's QuantStudio Absolute Q AutoRun dPCR Suite, released in 2023, automates laboratory workflows, increasing efficiency and lowering operational costs, whereas Roche's Digital LightCycler System, released in 2022, improved cancer detection and biomarker analysis capabilities. These advancements highlight the critical role of PCR enzymes in molecular diagnostics across oncology, infectious diseases, and genetic testing.

Molecular Diagnostic Raw Enzyme Market- Geographical Insights

North America represents a significant revenue-generating region in the Diagnostic Molecule Raw Enzymes Market in 2025, driven by a well-established healthcare infrastructure that supports advanced diagnostic testing. The region's adoption of innovative in-vitro diagnostic (IVD) platforms has increased the demand for raw enzymes used in various diagnostic applications. Additionally, rising investments in R&D, coupled with a growing patient population, have further contributed to the utilization of diagnostic molecule raw enzymes, reinforcing the region's importance in sustaining overall market growth.

Canada Molecular Diagnostic Raw Enzyme Market- Country Insights

The Canada Molecular Diagnostic Raw Enzyme Market is expected to grow significantly over the forecast period. The rising prevalence of cancer and other chronic diseases is increasing demand for advanced molecular diagnostic solutions that allow for early detection and personalized treatment. According to the Canadian Cancer Society, an estimated 247,100 Canadians will be diagnosed with cancer in 2024, up from 239,100 new cases in 2023, owing primarily to the country's aging and growing population. Furthermore, cancer-related deaths are expected to rise from 86,700 in 2023 to 88,100 in 2024, highlighting the growing need for accurate and timely diagnostic tools. This trend is expected to drive the adoption of molecular diagnostic raw enzymes, which are critical components in PCR, sequencing, and other diagnostic assays, boosting market growth in Canada.

Molecular Diagnostic Raw Enzyme Market- Competitive Landscape:

The Molecular Diagnostic Raw Enzyme Market has a moderately concentrated competitive landscape, with a few key players driving innovation and market expansion. Thermo Fisher Scientific, Merck KGaA, and New England Biolabs are among the key companies that specialize in the development of high-performance enzymes with improved stability, specificity, and reproducibility for molecular diagnostics applications such as PCR, NGS, and infectious disease testing. Merck KGaA, for example, released an upgraded version of its DNA polymerase enzyme in 2024, which improved amplification fidelity by 12% and increased efficiency in clinical diagnostic laboratories. The growing demand for accurate and reliable enzyme solutions, regulatory compliance, and the increasing adoption of advanced molecular testing technologies all influence market competition. Companies continue to invest in R&D, partnerships, and portfolio diversification to meet changing diagnostic needs in hospitals, research institutions, and IVD laboratories worldwide.

Recent Developments:

In June 2025, Enzo Biochem, Inc. announced that it had signed a definitive Agreement and Plan of Merger with Battery Ventures, a global technology investment firm. Battery, through its newly formed entity Bethpage Parent, Inc., will acquire Enzo for $0.70 per share in cash, for a total transaction value of approximately $37 million. This acquisition could have an impact on the distribution and availability of Enzo's enzyme assay kits, including those for alkaline phosphatase, lactate dehydrogenase, and glucose oxidase, as well as the company's overall diagnostics portfolio.

In September 2024, Promega unveiled a newly engineered polymerase intended to significantly reduce stuttering in forensic DNA analysis. By reducing stutter artifacts, the enzyme greatly simplifies the interpretation of mixed DNA samples, allowing forensic scientists to generate more accurate profiles from multiple sources. This breakthrough is the first enzyme designed specifically to address one of the most persistent challenges in DNA forensics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MOLECULAR DIAGNOSTIC RAW ENZYME MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • New England Biolabs (NEB)
  • QIAGEN
  • Bio-Rad Laboratories
  • Takara Bio
  • Aldevron
  • Codexis
  • Thermo Fisher Scientific
  • Vazyme Biotech
  • Qiagen
  • Fapon Biotech
  • Yeasen Biotechnology
  • Amano Enzyme Inc.
  • Advanced Enzymes Technologies Ltd.
  • Biocatalysts Ltd.
  • Enzo Life Sciences
  • MP Biomedicals
  • BBI Solutions
  • EKF Diagnostics
  • Medix Biochemica
  • Canvax Biotech
  • Others

GLOBAL MOLECULAR DIAGNOSTIC RAW ENZYME MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Polymerase Chain Reaction (PCR)
  • Others

GLOBAL MOLECULAR DIAGNOSTIC RAW ENZYME MARKET, BY ENZYME TYPE - MARKET ANALYSIS, 2019 - 2032

  • Polymerase & Transcriptase
  • Ribonuclease
  • Proteases
  • Others

GLOBAL MOLECULAR DIAGNOSTIC RAW ENZYME MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Biotech & Pharmaceutical Companies
  • Hospitals & Diagnostic Laboratories
  • Others

GLOBAL MOLECULAR DIAGNOSTIC RAW ENZYME MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Liver Function Biochemical Diagnosis
  • DNA Testing
  • Infectious Disease Diagnosis
  • Tumor Diagnosis
  • Coagulation Diagnosis
  • Others

GLOBAL MOLECULAR DIAGNOSTIC RAW ENZYME MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Infectious Diseases
  • Cardiology
  • Others

GLOBAL MOLECULAR DIAGNOSTIC RAW ENZYME MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Molecular Diagnostic Raw Enzyme Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Molecular Diagnostic Raw Enzyme Market Snippet by Technology
    • 2.1.2. Molecular Diagnostic Raw Enzyme Market Snippet by Enzyme Type
    • 2.1.3. Molecular Diagnostic Raw Enzyme Market Snippet by End-User
    • 2.1.4. Molecular Diagnostic Raw Enzyme Market Snippet by Application
    • 2.1.5. Molecular Diagnostic Raw Enzyme Market Snippet by Component
    • 2.1.6. Molecular Diagnostic Raw Enzyme Market Snippet by Country
    • 2.1.7. Molecular Diagnostic Raw Enzyme Market Snippet by Region
  • 2.2. Competitive Insights

3. Molecular Diagnostic Raw Enzyme Key Market Trends

  • 3.1. Molecular Diagnostic Raw Enzyme Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Molecular Diagnostic Raw Enzyme Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Molecular Diagnostic Raw Enzyme Market Opportunities
  • 3.4. Molecular Diagnostic Raw Enzyme Market Future Trends

4. Molecular Diagnostic Raw Enzyme Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Molecular Diagnostic Raw Enzyme Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Molecular Diagnostic Raw Enzyme Market Landscape

  • 6.1. Molecular Diagnostic Raw Enzyme Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Molecular Diagnostic Raw Enzyme Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 7.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
    • 7.1.3. Polymerase Chain Reaction (PCR)
    • 7.1.4. Others

8. Molecular Diagnostic Raw Enzyme Market - By Enzyme Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Enzyme Type, 2024 & 2032 (%)
    • 8.1.2. Polymerase & Transcriptase
    • 8.1.3. Ribonuclease
    • 8.1.4. Proteases
    • 8.1.5. Others

9. Molecular Diagnostic Raw Enzyme Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 9.1.2. Biotech & Pharmaceutical Companies
    • 9.1.3. Hospitals & Diagnostic Laboratories
    • 9.1.4. Others

10. Molecular Diagnostic Raw Enzyme Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Enzyme Type, 2024 & 2032 (%)
    • 10.1.2. Liver Function Biochemical Diagnosis
    • 10.1.3. DNA Testing
    • 10.1.4. Infectious Disease Diagnosis
    • 10.1.5. Tumor Diagnosis
    • 10.1.6. Coagulation Diagnosis
    • 10.1.7. Others

11. Molecular Diagnostic Raw Enzyme Market - By Component

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By Component, 2024 & 2032 (%)
    • 11.1.2. Oncology
    • 11.1.3. Infectious Diseases
    • 11.1.4. Cardiology
    • 11.1.5. Others

12. Molecular Diagnostic Raw Enzyme Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Molecular Diagnostic Raw Enzyme Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Molecular Diagnostic Raw Enzyme Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Molecular Diagnostic Raw Enzyme Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Molecular Diagnostic Raw Enzyme Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Molecular Diagnostic Raw Enzyme Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Molecular Diagnostic Raw Enzyme Industry

  • 13.1. Competitive Benchmarking
    • 13.1.1. Competitive Dashboard
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. New England Biolabs (NEB)
    • 13.2.2. QIAGEN
    • 13.2.3. Bio-Rad Laboratories
    • 13.2.4. Takara Bio
    • 13.2.5. Aldevron
    • 13.2.6. Codexis
    • 13.2.7. Thermo Fisher Scientific
    • 13.2.8. Vazyme Biotech
    • 13.2.9. Qiagen
    • 13.2.10. Fapon Biotech
    • 13.2.11. Yeasen Biotechnology
    • 13.2.12. Amano Enzyme Inc.
    • 13.2.13. Advanced Enzymes Technologies Ltd.
    • 13.2.14. Biocatalysts Ltd.
    • 13.2.15. Enzo Life Sciences
    • 13.2.16. MP Biomedicals
    • 13.2.17. BBI Solutions
    • 13.2.18. EKF Diagnostics
    • 13.2.19. Medix Biochemica
    • 13.2.20. Canvax Biotech
    • 13.2.21. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us